---
title: "TransCode Therapeutics (RNAZ.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/RNAZ.US/norm.md"
symbol: "RNAZ.US"
name: "TransCode Therapeutics"
parent: "https://longbridge.com/zh-HK/quote/RNAZ.US.md"
datetime: "2026-06-13T21:01:51.750Z"
locales:
  - [en](https://longbridge.com/en/quote/RNAZ.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RNAZ.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RNAZ.US/norm.md)
---

# TransCode Therapeutics (RNAZ.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -21.28 | -16.49 | -5.82 | -5.13 | -70.16 |
| ROE | -1347.07% | -1023.91% | -512.94% | -208.10% | -1168.52% |
| 營業收入 | - | - | - | - | - |
| 凈利潤 | -19.51M | -15.05M | -4.86M | -4.28M | -12.09M |
| 營業利潤 | -7.33M | -7.24M | -4.56M | -4.22M | -3.17M |
| 毛利率 | - | - | - | - | - |
| 凈利率 | - | - | - | - | - |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 157.16M | 162.40M | 5.23M | 8.27M | 13.19M |
| 權益乘數 | 1.09 | 1.07 | 3.67 | 1.34 | 1.28 |
| 每股凈資產 | 1.36 | 11.27 | 1.71 | 7.37 | 12.35 |
| 資產周轉率 | - | - | - | - | - |
| 現金及短投 | 12.84M | 17.81M | 2.84M | 7.37M | 11.57M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | 346745.00 | 370681.00 | 19908.00 | 24689.00 | 38131.00 |
| 凈債務 | -12.84M | -17.81M | -2.84M | -7.37M | -11.57M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -4.98M | -8.14M | -4.08M | -4.19M | -3.10M |
| 投資現金流 | - | -4436.00 | - | - | - |
| 融資現金流 | - | 23.12M | -455726.00 | 0.0000 | 8.85M |
| 自由現金流 | -2.42M | -6.15M | -2.36M | -2.83M | -2.19M |
| 現金流充裕率 | - | -122252.40% | - | - | - |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | - | -6660.00 | - | - | - |